Literature DB >> 11782538

Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine.

Ritu Banerjee1, Jun Liu, Wandy Beatty, Lorraine Pelosof, Michael Klemba, Daniel E Goldberg.   

Abstract

Hemoglobin degradation is a metabolic process that is central to the growth and maturation of the malaria parasite Plasmodium falciparum. Two aspartic proteases that initiate degradation, plasmepsins (PMs) I and II, have been identified and extensively characterized. Eight additional PM genes are present in the P. falciparum genome. To better understand the enzymology of hemoglobin degradation, it is necessary to determine which of these genes are expressed when hemoglobin degradation is occurring, which encode active enzymes, and which gene products are found in the food vacuole where catabolism takes place. Our genome-wide analysis reveals that PM I, II, and IV and histo-aspartic protease encode hemoglobin-degrading food vacuole proteases. Despite having a histidine in place of one of the catalytic aspartic acids conserved in other aspartic proteases, histo-aspartic protease is an active hydrolase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11782538      PMCID: PMC117418          DOI: 10.1073/pnas.022630099

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Comparative modelling and analysis of amino acid substitutions suggests that the family of pregnancy-associated glycoproteins includes both active and inactive aspartic proteinases.

Authors:  K Guruprasad; T L Blundell; S Xie; J Green; B Szafranska; R J Nagel; K McDowell; C B Baker; R M Roberts
Journal:  Protein Eng       Date:  1996-10

2.  Kinetic analysis of plasmepsins I and II aspartic proteases of the Plasmodium falciparum digestive vacuole.

Authors:  K E Luker; S E Francis; I Y Gluzman; D E Goldberg
Journal:  Mol Biochem Parasitol       Date:  1996-07       Impact factor: 1.759

3.  Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors.

Authors:  P J Rosenthal; J E Olson; G K Lee; J T Palmer; J L Klaus; D Rasnick
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

4.  The diversity and evolutionary relationships of the pregnancy-associated glycoproteins, an aspartic proteinase subfamily consisting of many trophoblast-expressed genes.

Authors:  S Xie; J Green; J B Bixby; B Szafranska; J C DeMartini; S Hecht; R M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway.

Authors:  I Y Gluzman; S E Francis; A Oksman; C E Smith; K L Duffin; D E Goldberg
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

6.  Biosynthesis and maturation of the malaria aspartic hemoglobinases plasmepsins I and II.

Authors:  S E Francis; R Banerjee; D E Goldberg
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

7.  Antimalarial activities of polyhydroxyphenyl and hydroxamic acid derivatives.

Authors:  K P Holland; H L Elford; V Bracchi; C G Annis; S M Schuster; D Chakrabarti
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

8.  Characterization of native falcipain, an enzyme involved in Plasmodium falciparum hemoglobin degradation.

Authors:  S E Francis; I Y Gluzman; A Oksman; D Banerjee; D E Goldberg
Journal:  Mol Biochem Parasitol       Date:  1996-12-20       Impact factor: 1.759

9.  Expression and characterisation of plasmepsin I from Plasmodium falciparum.

Authors:  R P Moon; L Tyas; U Certa; K Rupp; D Bur; C Jacquet; H Matile; H Loetscher; F Grueninger-Leitch; J Kay; B M Dunn; C Berry; R G Ridley
Journal:  Eur J Biochem       Date:  1997-03-01

10.  Sequence, expression and modeled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparum.

Authors:  J B Dame; G R Reddy; C A Yowell; B M Dunn; J Kay; C Berry
Journal:  Mol Biochem Parasitol       Date:  1994-04       Impact factor: 1.759

View more
  102 in total

1.  Fate of haem iron in the malaria parasite Plasmodium falciparum.

Authors:  Timothy J Egan; Jill M Combrinck; Joanne Egan; Giovanni R Hearne; Helder M Marques; Skhumbuzo Ntenteni; B Trevor Sewell; Peter J Smith; Dale Taylor; Donelly A van Schalkwyk; Jason C Walden
Journal:  Biochem J       Date:  2002-07-15       Impact factor: 3.857

2.  Unraveling the ubiquitome of the human malaria parasite.

Authors:  Nadia Ponts; Anita Saraf; Duk-Won D Chung; Alona Harris; Jacques Prudhomme; Michael P Washburn; Laurence Florens; Karine G Le Roch
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

3.  Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.

Authors:  T S Skinner-Adams; K T Andrews; L Melville; J McCarthy; D L Gardiner
Journal:  Antimicrob Agents Chemother       Date:  2006-11-06       Impact factor: 5.191

4.  Antimalarial effects of human immunodeficiency virus type 1 protease inhibitors differ from those of the aspartic protease inhibitor pepstatin.

Authors:  Sunil Parikh; Jun Liu; Puran Sijwali; Jiri Gut; Daniel E Goldberg; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

5.  Critical role of amino acid 23 in mediating activity and specificity of vinckepain-2, a papain-family cysteine protease of rodent malaria parasites.

Authors:  Ajay Singh; Bhaskar R Shenai; Youngchool Choe; Jiri Gut; Puran S Sijwali; Charles S Craik; Philip J Rosenthal
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

6.  Proteomic analysis of detergent-resistant membrane microdomains in trophozoite blood stage of the human malaria parasite Plasmodium falciparum.

Authors:  Xue Yan Yam; Cecilia Birago; Federica Fratini; Francesco Di Girolamo; Carla Raggi; Massimo Sargiacomo; Angela Bachi; Laurence Berry; Gamou Fall; Chiara Currà; Elisabetta Pizzi; Catherine Braun Breton; Marta Ponzi
Journal:  Mol Cell Proteomics       Date:  2013-09-17       Impact factor: 5.911

7.  Interactions of different inhibitors with active-site aspartyl residues of HIV-1 protease and possible relevance to pepsin.

Authors:  Jane M Sayer; John M Louis
Journal:  Proteins       Date:  2009-05-15

8.  Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.

Authors:  Koushi Hidaka; Tooru Kimura; Adam J Ruben; Tsuyoshi Uemura; Mami Kamiya; Aiko Kiso; Tetsuya Okamoto; Yumi Tsuchiya; Yoshio Hayashi; Ernesto Freire; Yoshiaki Kiso
Journal:  Bioorg Med Chem       Date:  2008-10-10       Impact factor: 3.641

9.  Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria.

Authors:  Roberta Spaccapelo; Chris J Janse; Sara Caterbi; Blandine Franke-Fayard; J Alfredo Bonilla; Luke M Syphard; Manlio Di Cristina; Tania Dottorini; Andrea Savarino; Antonio Cassone; Francesco Bistoni; Andrew P Waters; John B Dame; Andrea Crisanti
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

10.  Gene disruption confirms a critical role for the cysteine protease falcipain-2 in hemoglobin hydrolysis by Plasmodium falciparum.

Authors:  Puran S Sijwali; Philip J Rosenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.